Nuo Therapeutics, Inc. Common Stock Shares Outstanding

• Nuo Therapeutics, Inc. showed an increase of +2.9% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from Nuo Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2010 to 2025 (22 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 22 years of available data (2010 to 2025), Nuo Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 9.2%.
• Historical annual values: Fiscal year 2025: 48.18 million shares | Fiscal year 2024: 46.82 million shares | Fiscal year 2023: 44.24 million shares | Fiscal year 2022: 41.80 million shares | Fiscal year 2021: 37.12 million shares | Fiscal year 2021: 30.26 million shares | Fiscal year 2021: 30.26 million shares | Fiscal year 2021: 30.26 million shares | Fiscal year 2020: 30.26 million shares | Fiscal year 2020: 24.25 million shares | Fiscal year 2020: 24.25 million shares | Fiscal year 2020: 24.25 million shares | Fiscal year 2019: 23.72 million shares | Fiscal year 2018: 23.72 million shares | Fiscal year 2017: 22.72 million shares | Fiscal year 2016: 9.93 million shares | Fiscal year 2015: 125.68 million shares | Fiscal year 2014: 125.68 million shares | Fiscal year 2013: 107.16 million shares | Fiscal year 2012: 93.81 million shares | Fiscal year 2011: 55.54 million shares | Fiscal year 2010: 44.10 million shares.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026